A Study About Safety and Efficacy of Pirfenidone to Treat Grade 2 or Grade3 Radiation-induced Lung Injury.
Clinical trial NCT03902509 · COMPLETED
Trial details
- NCT number
- NCT03902509
- Sponsor
- Beijing Continent Pharmaceutical Co, Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-24
- Primary completion
- 2023-12-04
- Enrollment
- 126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.